A Weekly Health Policy Round-Up From Health Affairs
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Problems viewing this email?
The Latest Research, Commentary, And News From Health Affairs

August 29, 2021
Dear John,

Look for Health Affairs’ Back-To-School Essentials in next week’s newsletters. Make sure the future health policy leaders in your life sign up to receive all the info.

Read on for highlights from Health Affairs this week.

What's New In Health Affairs
The GrantWatch column in the August 2021 issue is about foundations around the United States awarding funding related to Medicaid.

In 2022 a Robert Wood Johnson Foundation national program will fund studies to look at policy changes made to Medicaid during the pandemic "and examine their impact on communities of color and/or explore how current or proposed policies may alleviate or exacerbate racial inequity and structural racism."

This week on Health Affairs Blog, Katherine LeMasters and coauthors discussed the increased risks for HIV and COVID-19 for people involved in the criminal justice system and their communities.


Katie Keith discussed the new frequently asked questions issued by the Departments of Labor, Health and Human Services, and the Treasury on the implementation of various transparency requirements under the Consolidated Appropriations Act.

Two new podcasts were released this week: A Health Podyssey with Alan Weil and Scott Howell, and This Week's Back To School episode, with Rob Lott and Jessica Bylander.

Featured This Week
A Health Podyssey
Scott Howell On The Very Large Costs Of Drug Utilization Management

Health Affairs Editor-in-Chief Alan Weil interviews Scott Howell, chief strategy officer for US pharmaceuticals at Novartis Pharmaceuticals, on drug utilization management and the tension between drug manufacturers and pharmaceutical benefit designs.
On The Blog This Week
Defending Syringe Services Programs
Jennifer D. Oliva et al.

COVID-19 And HIV: Overlapping Pandemics For Criminal Justice-Involved Individuals
Katherine LeMasters et al.

Filling In The Medicaid Gap Without Paying For It Twice
Linda J. Blumberg and Sherry Glied

New Guidance On Transparency Requirements, Advanced Explanations Of Benefits, And More
Katie Keith

Clinical Trials In Crisis: Building On COVID-19’s Lessons Toward A Better Future
Esther Krofah et al.

A Way Forward For The Imaging Appropriate Use Criteria Program: Aligning Quality Metrics
Andrew Menard et al.

The Public Option Finds An Uncommon Ally In Medicaid In Nevada
Stacie Weeks et al.

Shift Work Is Harmful But Unavoidable: What's The Best Way To Address It?
Megan McHugh et al.


Building A Resilient Rx Drug Supply: A New HHS Office And Other Steps
Rena M. Conti and Fiona Scott Morton

Framework For Specialty Value Transformation: Perspectives From A Commercial Payer
David C. Johnson et al.

Health Affairs This Week
Back To School Edition: COVID-19 Vaccines & Mask Mandates

Listen to Health Affairs' Rob Lott and Jessica Bylander talk about the latest developments on COVID-19 vaccines and mask mandates as public schools begin to reopen.
 
Preorder next month's issue!
 
 
 
 
About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.  

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here
.